EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro and in vivo neutralization of Dengue virus by a single domain antibody

Surbhi Dahiya, Sudhakar Singh, Gaurav Kumar Bhati, Sharvan Sehrawat iD

ImmunoHorizons · 2025

DOI: 10.1093/immhor/vlaf012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoHorizons, 2025. Verfasst von Surbhi Dahiya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Indian Institute of Science Education and Research, Manauli, Punjab, India. Hauptthemen laut MEDLINE: Dengue Virus, Single-Domain Antibodies, Antibodies, Neutralizing, Dengue. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IISER Mohali, Scientific and Engineering Research Board, Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To alleviate the contribution of antibody dependent enhancement in DenV pathogenesis, we obtain a DenV neutralizing single domain antibody (sdAb) from an in-house constructed phage display library of camelid VHH. The anti-DenV sdAb specifically reacts with the envelope (E) protein of DenV with a Kd value of 2x108. Molecular dynamic simulations and docking analysis show that the sdAb interacts with the DenV(E) protein via domain II (EDII) and interferes with the virus internalization process. The anti-DenV(E) sdAb potently inhibits the infectivity of a DenV(E) protein expressing pseudovirus as well as that of a virulent DenV in vitro. A mouse adapted DenV2 induces 100% mortality in the infected IFNRKO mice, but the animals injected with the sdAb neutralized virus remain fully protected. Furthermore, the therapeutically administered anti-DenV(E) sdAb slows down the disease progression and enhances the survival of DenV infected animals. In conclusion, we report an anti-DenV(E) sdAb as a potential therapy to manage DenV pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusSingle-Domain AntibodiesAntibodies, NeutralizingDengueAntibodies, ViralAnimalsMiceViral Envelope ProteinsHumansMice, KnockoutMolecular Docking SimulationMolecular Dynamics SimulationPeptide LibraryVirus InternalizationNeutralization Tests

Stichwörter der Autor:innen

Dengue virusantibody dependent enhancementnanobodiesneutralizing single domain antibodies

Substanzen

Single-Domain AntibodiesAntibodies, NeutralizingAntibodies, ViralViral Envelope ProteinsPeptide Library

Autor:innen und Institutionen

  • Department of Biological Sciences, Indian Institute of Science Education and Research, Manauli, Punjab, India.

ORCID-Profile: Sharvan Sehrawat

Förderung

  • IISER Mohali
  • Scientific and Engineering Research Board, Department of Science and Technology

Zitieren

APA

Dahiya, S., Singh, S., Bhati, G. K., & Sehrawat, S. (2025). In vitro and in vivo neutralization of Dengue virus by a single domain antibody. ImmunoHorizons. https://doi.org/10.1093/immhor/vlaf012

Vancouver

Dahiya S, Singh S, Bhati GK, Sehrawat S. In vitro and in vivo neutralization of Dengue virus by a single domain antibody. ImmunoHorizons. 2025. doi:10.1093/immhor/vlaf012

BibTeX
@article{Dahiya2025,
  author = {Dahiya, Surbhi and Singh, Sudhakar and Bhati, Gaurav Kumar and Sehrawat, Sharvan},
  title = {In vitro and in vivo neutralization of Dengue virus by a single domain antibody},
  journal = {ImmunoHorizons},
  year = {2025},
  doi = {10.1093/immhor/vlaf012}
}
Kostenlos starten →